NHS England plans a phased rollout of tirzepatide to treat severe obesity, with early trials showing significant weight loss. Digital clinics and multidisciplinary teams will deliver the drug to 240,000 people initially. read more
England’s NHS Proposes Phased Rollout of Eli Lilly’s Mounjaro, Considers Digital Services to Boost Access